British HIV Association opportunistic infection guidelines: in defence of amphotericin B deoxycholate
- 11 October 2012
- journal article
- Published by Wiley in HIV Medicine
- Vol. 13 (10) , 636-637
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- 2 Central nervous system opportunistic infectionsHIV Medicine, 2011
- Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS‐Associated Acute Cryptococcal Meningitis: A Randomized, Double‐Blind Clinical Trial of Efficacy and SafetyClinical Infectious Diseases, 2010
- Combination Flucytosine and High‐Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in MalawiClinical Infectious Diseases, 2010
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010
- Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 PatientsClinical Infectious Diseases, 2009
- Dose Response Effect of High‐Dose Fluconazole for HIV‐Associated Cryptococcal Meningitis in Southwestern UgandaClinical Infectious Diseases, 2008
- High‐Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV‐Infected Patients: A Randomized TrialClinical Infectious Diseases, 2008
- Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2008
- Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and reviewJournal of Infection, 2005
- Mortality and Costs of Acute Renal Failure Associated with Amphotericin B TherapyClinical Infectious Diseases, 2001